Innovations in biomarker detection and personalized medicine for prostate cancer

FHS
August 23, 2024
11:41 pm

In a recent comprehensive review published in Cyborg Bionic Systems, researchers led by Keyi Li from the General Hospital of Northern Theater Command in Shenyang, along with international collaborators, detail significant advances in the identification and application of biomarkers for prostate cancer (PCa).

GLP-1 drugs may reduce pancreatitis risk in obese and diabetic patients

Medications for type 2 diabetes and obesity known as GLP-1 receptor agonists may lower the risk of acute pancreatitis recurrence in people with obesity and

June 3, 2024

Advances in ALL at ASH Meeting Include New Blinatumomab Data and More

In the phase III ECOG-ACRIN E1910 study presented at the American Society of Hematology (ASH) annual meeting, consolidation chemotherapy with blinatumomab (Blincyto) improved overall survival

December 19, 2024

Why a Medtronic exec thinks a convergence of med tech and consumer tech is coming

(This story is from our new Health Tech newsletter. If you’d like to sign up, just click here.) Medtronic is getting ready for a world

April 5, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.